EU blocks merger of US firms in cancer screening sector
The European Commission is is blocking the buyout of cancer-screening company GRAIL by biotech giant Illumina. It's a rare move by European antitrust regulators against two U.S. co…
The European Commission is is blocking the buyout of cancer-screening company GRAIL by biotech giant Illumina. It's a rare move by European antitrust regulators against two U.S. co…